Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has submitted the disclosure of Related Party Transactions for the half year / six months ended 31st March, 2023. The same is also being made available on the website of the Company at www.glenmarkpharma.com.
The above information is a part of company’s filings submitted to BSE.